Comparative haemodynamic effects of intravenous lignocaine, disopyramide and flecainide in uncomplicated acute myocardial infarction.
暂无分享,去创建一个
S. Taylor | B. Silke | G. Reynolds | M. Frais | P. Kalra | M. Hafizullah | S. Verma | N. Jackson
[1] B. Silke,et al. Hemodynamic dose‐response effects of flecainide in acute myocardial infarction with and without left ventricular decompensation , 1985, Clinical pharmacology and therapeutics.
[2] J. Johnson,et al. Quantitation of flecainide acetate, a new antiarrhythmic agent, in biological fluids by gas chromatography with electron-capture detection. , 1984, Journal of pharmaceutical sciences.
[3] B. Singh,et al. Effects of flecainide on ventricular function: clinical and experimental correlations. , 1984, The American journal of cardiology.
[4] J. Anderson,et al. A proposal for the clinical use of flecainide. , 1984, The American journal of cardiology.
[5] R. Norris,et al. Intravenous Disopyramide in Acute Myocardial Infarction: A Haemodynamic and Pharmacokinetic Study , 1984, Journal of cardiovascular pharmacology.
[6] P. Serruys,et al. The haemodynamic effect of intravenous flecainide acetate in patients with coronary artery disease. , 1983, British journal of clinical pharmacology.
[7] V. Legrand,et al. Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease. , 1983, The American journal of cardiology.
[8] G. Sutton,et al. A long-term prevention study with oxprenolol in coronary heart disease. , 1982, The New England journal of medicine.
[9] L. Griffith,et al. Suppression of complex ventricular arrhythmias by oral flecainide , 1982, Clinical pharmacology and therapeutics.
[10] A. Camm,et al. Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man. , 1982, British heart journal.
[11] R. Asinger,et al. Suppression of Ventricular Ectopic Depolarizations by Flecainide Acetate, A New Antiarrhythmic Agent , 1982, Circulation.
[12] D. Roden,et al. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide. , 1981, The American journal of cardiology.
[13] B. Pitt,et al. Oral flecainide acetate for the treatment of ventricular arrhythmias. , 1981, The New England journal of medicine.
[14] Mike W. S. Martin. The management of arrhythmias. , 2008, Medical times.
[15] R. Schröder,et al. Effects of disopyramide on systemic and coronary hemodynamics and myocardial metabolism in patients with coronary artery disease: comparison with lidocaine. , 1980, The American journal of cardiology.
[16] R. Mccomb,et al. Simultaneous liquid-chromatographic determination of three antiarrhythmic drugs: disopyramide, lidocaine, and quinidine. , 1980, Clinical Chemistry.
[17] J. Koch-weser. Drug therapy: bretylium. , 1979, The New England journal of medicine.
[18] J. Vogt,et al. [The comparative hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction (comparison of propafenone and lidocaine) (author's transl)]. , 1978, Zeitschrift fur Kardiologie.
[19] G. Rosenhamer,et al. Hemodynamic and electrocardiographic effects of disopyramide in patients with ventricular arrhythmia. , 2009, Acta medica Scandinavica.
[20] P. Armstrong,et al. Comparative effects of lidocaine and procainamide on acutely impaired hemodynamics. , 1976, The American journal of medicine.
[21] A. Niarchos. Disopyramide: serum level and arrhythmia conversion. , 1976, American heart journal.
[22] R. Miller,et al. Hemodynamic effects of procainamide in patients with acute myocardial infarction and comparison with lidocaine. , 1973, The American journal of medicine.
[23] K. Rosen,et al. Lidocaine infusion in acute myocardial infarction. Effects on left ventricular function. , 1971, Archives of internal medicine.
[24] J. Frieden,et al. Cardiovascular effects of infusion of lidocaine on patients with heart disease. , 1969, The American journal of cardiology.
[25] H. Blackburn,et al. Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.
[26] John F. Williams,et al. Hemodynamic Effects of Lidocaine in Patients with Heart Disease , 1968, Circulation.